RAVICTI
RAVICTI
Approved
DIN Number
02453304
Drug Class
Human
Market Date
Nov 3, 2016
Company
HC
HORIZON THERAPEUTICS IRELAND DAC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02453304
AIG Number0157990001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A16AX09 GLYCEROL PHENYLBUTYRATE
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
Health Canada Classification
ACTIVE INGREDIENTS (1)
GLYCEROL PHENYLBUTYRATEActive
Strength: 1.1 G / ML
Monograph: GLYCEROL PHENYLBUTYRATE